Related references
Note: Only part of the references are listed.Design, Synthesis and Pharmacological Characterization of Endomorphin Analogues with Non-Cyclic Amino Acid Residues in Position 2
Renata Perlikowska et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Bi- or multifunctional opioid peptide drugs
Peter W. Schiller
LIFE SCIENCES (2010)
Synthesis and biological evaluation of cyclic endomorphin-2 analogs
Renata Perlikowska et al.
PEPTIDES (2010)
Biological activity of endomorphin and [Dmt1] endomorphin analogs with six-membered proline surrogates in position 2
Renata Perlikowska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Synthesis and evaluation of new endomorphin analogues modified at the Pro2 residue
Domenica Torino et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Recent Advances in Medicinal Chemistry and Pharmaceutical Technology-Strategies for Drug Delivery to the Brain
Nunzio Denora et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Structure-activity study of endomorphin-2 analogs with C-terminal modifications by NMR spectroscopy and molecular modeling
Chang-lin Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides
Yasuko Koda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and biological activity of endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic acids instead of proline in position 2
Renata Staniszewska et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Investigation of the interaction between the atypical agonist c[YpwFG] and MOR
Luca Gentilucci et al.
FEBS JOURNAL (2008)
In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue
Yasuko Koda et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Endomorphin-2 with a β-turn backbone constraint retains the potent μ-opioid receptor agonist properties
Csaba Tomboly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
New endomorphin analogues containing alicyclic β-amino acids:: Influence on bioactive conformation and pharmacological profile
Attila Keresztes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Enzymatic degradation of endomorphins
Anna Janecka et al.
PEPTIDES (2008)
A new opioid designed multiple ligand derived from the μ opioid agonist endomorphin-2 and the δ opioid antagonist pharmacophore Dmt-Tic
Severo Salvadori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Bifunctional [2′,6′-Dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed μ-agonist/δ-antagonist and dual μ-agonist/δ-agonist opioid ligands
Tingyou Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Differential receptor binding characteristics of consecutive phenylalanines in μ-opioid specific peptide ligand endomorphin-2
Takeshi Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Structure-activity study on the spatial arrangement of the third aromatic ring of endomorphins 1 and 2 using an atypical constrained C terminus
Ye Yu et al.
CHEMMEDCHEM (2007)
Synthesis and analgesic activities of endomorphin-2 and its analogues
Zhi-Hao Shi et al.
CHEMISTRY & BIODIVERSITY (2007)
Endomorphin analogs
Anna Janecka et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1
Hong-Mei Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Glycopeptides as versatile tools for glycobiology
Therese Buskas et al.
GLYCOBIOLOGY (2006)
Opioid receptor binding and antinociceptive activity of the analogues of endomorphin-2 and morphiceptin with phenylalanine mimics in the position 3 or 4
Yanfeng Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
6-N,N-dimethylamino-2,3-naphthalimide:: A new environment-sensitive fluorescent probe in δ- and μ-selective opioid peptides
M. Eugenio Vazquez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors
Richard S. Agnes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Unusual amino acids: Synthesis and introduction into naturally occurring peptides and biologically active analogues
G Cardillo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acids
A Janecka et al.
PEPTIDES (2006)
Opioid peptides: Synthesis and biological activity of new endomorphin analogues
Barbara Biondi et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2006)
CNS drug delivery: Opioid peptides and the blood-brain barrier
KA Witt et al.
AAPS JOURNAL (2006)
Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series
DJ Daniels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs
A Janecka et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Synthesis and biological activity of N-methylated analogs of endomorphin-2
R Kruszynski et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Endomorphin 1[ψ] and endomorphin 2[ψ], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception
QY Zhao et al.
LIFE SCIENCES (2005)
Structure-activity relationships of novel endomorphin-2 analogues with N-O turns induced by α-aminoxy acids
J Wei et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid mimics active conformation of tyrosine in opioid peptides
E Sperlinga et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2
YF Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse
Y Jinsmaa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Development of potent μ-opioid receptor ligands using unique tyrosine analogues of endomorphin-2
TY Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Transport systems for opioid peptides in mammalian tissues
V Ganapathy et al.
AAPS JOURNAL (2005)
Conformationally restricted peptides as tools in opioid receptor studies
A Janecka et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position
J Fichna et al.
BIOCHEMICAL PHARMACOLOGY (2005)
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
I Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Spinal antinociceptive effects of AA501, a novel chimeric peptide with opioid receptor agonist and tachykinin receptor antagonist moieties
IM Bonney et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
A chimeric opioid peptide with mixed μ agonist δ antagonist properties
G Weltrowska et al.
JOURNAL OF PEPTIDE RESEARCH (2004)
Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues
C Tömböly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells
KA Horner et al.
BRAIN RESEARCH (2004)
(4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligands
RE Dolle et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Development of potent bifunctional endomorphin-2 analogues with mixed μ-/δ-opioid agonist and δ-opioid antagonist properties
Y Fujita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction
W Puehler et al.
NEUROSCIENCE (2004)
Synthesis and evaluation of the affinity toward μ-opioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-]
G Cardillo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
New endomorphin analogs with μ-agonist and δ-antagonist properties
G Tóth et al.
PURE AND APPLIED CHEMISTRY (2004)
Opioid receptors and their ligands
A Janecka et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
New trends in the development of opioid peptide analogues as advanced remedies for pain relief
L Gentilucci
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Recent advances in the investigation of the bioactive conformation of peptides active at the mu-opioid receptor. Conformational analysis of endomorphins
L Gentilucci et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons
KJ Powell et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain
VJ Hruby et al.
LIFE SCIENCES (2003)
Antinociception by a peripherally administered novel endomorphin-1 analogue containing β-proline
S Spampinato et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Glycopeptide-membrane interactions: Glycosyl enkephalin analogues adopt turn conformations by NMR and CD in amphipathic media
MM Palian et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Stability against enzymatic hydrolysis of endomorphin-1 analogues containing β-proline
G Cardillo et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2003)
Structural studies of [2′,6′-dimethyl-L-tyrosine1]endomorphin-2 analogues:: Enhanced activity and cis orientation of the Dmt-Pro amide bond
Y Okada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Endomorphin 2 analogues containing dmp residue as an aromatic amino acid surrogate with high g-opioid receptor affinity and selectivity
Y Sasaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Unpredictable stereochemical preferences for Mu opioid receptor activity in an exhaustively stereodiversified library of 1,4-enediols
ZJ Shi et al.
ORGANIC LETTERS (2003)
2,6-dimethyltyrosine analogues of a stereodiversified ligand library:: Highly potent, selective, non-peptidic μ opioid receptor agonists
BA Harrison et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis and evaluation of potential affinity labels derived from endomorphin-2
H Choi et al.
JOURNAL OF PEPTIDE RESEARCH (2003)
Dmt and opioid peptides: A potent alliance
SD Bryant et al.
BIOPOLYMERS (2003)
Endomorphin analogues containing D-Pro2 discriminate different μ-opioid receptor mediated antinociception in mice
S Sakurada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
High-affinity muopioid receptor ligands discovered by the screening of an exhaustively stereodiversified library of 1,5-enediols
BA Harrison et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II
VS Hau et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
The structure of an endomorphin analogue incorporating 1-aminocyclohexane-1-carboxlylic acid for proline is similar to the β-turn of Leu-enkephalin
M Doi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
In vitro quantitative study of the degradation of endomorphins
C Tömböly et al.
PEPTIDES (2002)
Synthesis and biological activities of cyclic lanthionine enkephalin analogues:: δ-opioid receptor selective ligands
Y Rew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Endomorphin-1 analogues containing β-proline are μ-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance
G Cardillo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Design, synthesis, and evaluation of opioid analogues with non-peptidic β-turn scaffold:: Enkephalin and endomorphin mimetics
M Eguchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Side chain modifications change the binding and agonist properties of endomorphin 2
I Lengyel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
KA Witt et al.
PEPTIDES (2001)
Pseudoproline-containing analogues of morphiceptin and endomorphin-2:: Evidence for a cis Tyr-Pro amide bond in the bioactive conformation
M Keller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Conformational comparison of μ-selective endomorphin-2 with its C-terminal free acid in DMSO solution, by 1H NMR spectroscopy and molecular modeling calculation
Y In et al.
JOURNAL OF PEPTIDE RESEARCH (2001)
[2′,6′-dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group:: Potent and selective κ opioid antagonists
YX Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Receptor constants for endomorphin-1 and endomprphin-1-ol indicate differences in efficacy and receptor occupancy
M Al-Khrasani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Acute opioid receptor desensitization and tolerance: Is there a link?
S Borgland
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2001)
Stereospecific synthesis of (2S)-2-methyl-3-(2′,6′-dimethyl-4′-hydroxyphenyl)-propionic acid (Mdp) and its incorporation into an opioid peptide
YX Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Synthesis and binding activity of endomorphin-1 analogues containing β-amino acids
G Cardillo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Dissociation of analgesic and rewarding effects of endomorphin-1 in rats
AM Wilson et al.
PEPTIDES (2000)
Improved bioavailability to the brain of glycosylated Met-enkephalin analogs
RD Egleton et al.
BRAIN RESEARCH (2000)
Synthesis of stereoisomeric analogues of endomorphin-2, H-Tyr-Pro-Phe-Phe-NH2, and examination of their opioid receptor binding activities and solution conformation
Y Okada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine
MA Czapla et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Oligomerization of μ- and δ-opioid receptors -: Generation of novel functional properties
SR George et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice
RD Soignier et al.
LIFE SCIENCES (2000)
Determinants of passive drug entry into the central nervous system
MD Habgood et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
Stereochemical requirements for receptor recognition of the μ-opioid peptide endomorphin-1
MG Paterlini et al.
BIOPHYSICAL JOURNAL (2000)
Tight junctions of the blood-brain barrier
U Kniesel et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
Synthesis and binding properties of endomorphin-2 analogs containing alpha-hydroxymethyl amino acids
A Olma et al.
LETTERS IN PEPTIDE SCIENCE (2000)
Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads
VJ Hruby et al.
CURRENT MEDICINAL CHEMISTRY (2000)
Share Paper
